Chih-Yi Hsieh

Senaparib as first-line maintenance therapy in advanced ovarian cancer: a randomized phase 3 trial

Xiaohua Wu, Jihong Liu, Jing Wang et al. · Nature Medicine · 2024 · 37 citations

Medicine, Oncology, Pharmacotherapy +11

Safety and efficacy of nilotinib in routine clinical practice in patients with chronic myeloid leukemia in chronic or accelerated phase with resistance or intolerance to imatinib: results from the NOVEL study

Ching‐Yuan Kuo, Po‐Nan Wang, Wen‐Li Hwang et al. · Therapeutic Advances in Hematology · 2018 · 15 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Efficacy and safety of varlitinib, a reversible pan-HER tyrosine kinase inhibitor, in combination with platinum-based regimens in biliary tract cancers: A pooled analysis from three phase I studies.

Aaron C. Tan, Do‐Youn Oh, Yee Chao et al. · Journal of Clinical Oncology · 2019 · 14 citations

Medicine, Oncology, Pharmacology +14

A phase 1 dose-escalation and -expansion study of IMP7068, a WEE1 inhibitor, in patients with advanced solid tumors.

Chia‐Chi Lin, Jaspreet Singh Grewal, David Sommerhalder et al. · Journal of Clinical Oncology · 2022 · 10 citations

Medicine, Oncology, Pharmacology +14